{"nct_id":"NCT03525444","title":"A Phase 3 Study of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)","status":"COMPLETED","status_verified_date":"2020-05","start_date":"2018-06-15","start_date_type":"ACTUAL","primary_completion_date":"2019-04-24","primary_completion_date_type":"ACTUAL","completion_date":"2019-04-24","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["VRTX"]}